Anika Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Anika Therapeutics (ANIK) Tops Q1 EPS
May 7, 2020 5:06 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.45, $0.51 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $35.4 million versus the consensus estimate of $31.53 million.
Anika delivered solid first quarter results and made significant progress towards advancing our strategic plan, including... More
